Safoora Nikzad

Dr. Safoora Nikzad


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2018 in Iranian Journal of Radiology
Verified
Journal Article
Open access
PDF file
SNSafoora Nikzad
Safoora Nikzad
MPMaryam Pourkaveh
Maryam Pourkaveh
NVNaghi Jabbari Vesal
Naghi Jabbari Vesal
FGFarideh Gharekhanloo
Farideh Gharekhanloo
Background: Diagnostic radiology by the use of ionizing radiation plays a main contribution in the collective dose of human population. Knowing the radiation dose received by patients during a radiological examination is essential to prevent the excess health risk of exposure. Objectives: The aim of this study was to estimate the collective dose and calculate the cancer risk probability due to common radiological procedures in four radiology imaging centers of Iran. Patients and Methods: Four hundred seventy patients who underwent different radiological examinations including the skull, chest, abdomen, pelvis, lumbar, cervical and thoracic regions in four radiology centers of Hamadan, Iran were studied. The patients’ entrance surface dose (ESD) was measured, and eventually, the effective dose (ED) was calculated. These parameters were compared with the reported values and international standard levels. Finally, the risk of cancer was determined by two different methods proposed in international commission on radiological protection (ICRP) 103. Results: Mean values of ESD for chest, abdomen, pelvis, lumbar region, skull, cervical and thoracic regions were 0.43 ± 0.09, 2.51 ± 0.19, 2.47 ± 0.02, 3.21 ± 0.17, 2.15 ± 0.11, 1.35 ± 0.15, and 2.51 ± 0.19 mGy, respectively. The mean values of ED were 0.05, 0.33, 0.25, 0.42, 0.02, 0.05 and 0.24 mSv, respectively for these organs. The cancer risk probability as a function of cumulative dose was 0.20, 1.21, 0.08, 1.32, 0.01, 0.01 and 0.04 (person - Sv × 5% per Sievert) for the interested organs, respectively. The risk of cancer as a function of age and sex for male patients was 0.86, 1.47, 0.59, 0.02, 0.16, 1.96 and 0.76 (in 103 person) for the bladder, colon, liver, thyroid, esophagus, lung and stomach, respectively. These values were, 0.34 (or 2.12), 0.73 (or 4.47), 0.98, 0.43, 0.72, 0.19, 0.25, 0.26 and 1.20 (in 103 persons) for breast, lung, bladder, ovary, colon, liver, thyroid, esophagus and stomach for females. Conclusions: Results show that the estimated health risk based on ICRP health risk of 500 cases per 10000 person - Sv (5% per Sievert) was in total about 2 cases for seven examinations in 2016. Risks of cancer as a function of age and sex for male patients were higher for lung and colon cancers and for females, it was higher for breast and lung cancers. Keywords: Diagnostic Radiology; Cumulative Dose; Entrance Surface Dose; Effective Dose; Cancer Risk Estimation

1 July 2021 in Journal of Applied Sciences and Nanotechnology
Verified
Journal Article
Open access
PDF file
AJAsef Josheghanian
Asef Josheghanian
EAEhsan Akbari-Hamed
Ehsan Akbari-Hamed
EKElham Khanlarzadeh
Elham Khanlarzadeh
MGMohammad Hadi Gholami
Mohammad Hadi Gholami
SNSafoora Nikzad
Safoora Nikzad
This study aimed to evaluate the effect of various factors and treatments protocols' outcomes on the survival of patients with gastric cancer (GC). In a retrospective cohort study Patients with a definite diagnosis of GC who had been hospitalized at the Mahdie Hospital of Hamadan, Iran, from 2005-2017 were investigated. GC-related survival for different factors, types, locations of the tumor, sites of metastasis, and used treatment methods investigated. Data analyze performed by SPSS software version 21. 95 patients, including 66 (71%) male, and 27 (29%) female, were identified. The mean age was 63.88±12.41 years. The largest proportion of tumors was located in the cardia (29.7%), body (18.9%), and antrum (18.9%) of the stomach. The most common site of metastasis was the liver (52.6%), and lung (26.3%). The average survival of patients was 40.64±4.58 months, and the one, two, three, four, and five years’ survival of investigated patients were 0.68, 0.49, 0.43, 0.39, and 0.34 years, respectively. The average survival of patients with and without metastasis were 16.35±3.27 and 46.97±5.30 months (P=0.004). The Pearson correlation coefficient between the survival and total dose of RT, total number of CT sessions, and dose of each RT session were -0.003 (P-value=0.98), 0.006 (P-value=0.97), and -0.108 (P-value=0.412), respectively. Results show that there were no statistically significant differences between the average survival of patients and used treatment method, grade, type of cancer, and CT medicine. But survival of patients with metastasis was significantly lower than patients without metastasis (P=0.029).

1 March 2023 in Current Radiopharmaceuticals
Verified
Journal Article
Closed access
PDF file
SNSafoora Nikzad
Safoora Nikzad
MAMohammad Hootan Ahmadvand
Mohammad Hootan Ahmadvand
SHSayed Payam Hashemi
Sayed Payam Hashemi
AKAlireza Khoshghadam
Alireza Khoshghadam
FKFereshte Kalhori
Fereshte Kalhori
FMFatemeh Mirzaei
Fatemeh Mirzaei
Background: During a radiological or nuclear disaster, exposure to a high dose of ionizing radiation usually results in cardiovascular diseases such as heart failure, attack, and ischemia. Objective: the purpose of this study was to examine mitigation effects of Spirulina in comparison to Metformin's. Materials and Methods: 25 male Wistar rats were randomly assigned to five groups (5 rats in each): for the control group, rats did not receive any intervention. In group 2, spirulina was administered orally to rats. In group 3, rats were irradiated to the chest region with 15 Gray(Gy) x-radiation. In groups 4 and 5, The rats were irradiated in the same way as group 3. Forty-eight hours after irradiation, treatment with Spirulina and Metformin began. All rats were sacrificed after ten weeks and their heart tissues were removed for histopathological, and biochemical assays. Results: Results showed an elevation in Malondialdehyde (MDA) and decreasing superoxide dismutase (SOD) activity. Moreover, pathological changes of radiation were irregularities in the arrangement of myofibrils, proliferation, migration of mononuclear cells, vacuolation of the cytoplasm, and congestion. Administration of spirulina enhance the SOD activity while did not affect MDA level and pathological change in heart tissue. Despite spirulina, metformin had a considerable effect on pathological lesions and decrease the level of MDA. Conclusion: reactive oxygen species (ROS) may be involved in the late effects of radiation-induced heart injury and scavenging these particles may contribute to reduced radiation side effects. Based on these results, Spirulina had no effect on radiation-induced cardiac damage, while metformin did. Higher Spirulina doses given over a longer period of time will likely have a greater heart-mitigate effect.

1 April 2018 in Pajouhan Scientific Journal
Verified
Journal Article
Open access
PDF file
NVNaghi Jabbari Vesal
Naghi Jabbari Vesal
NRNima Rostampour
Nima Rostampour
RPRoghaie Abbasali Pourkabir
Roghaie Abbasali Pourkabir
SNSafoora Nikzad
Safoora Nikzad

1 February 2023 in Advanced Biomedical Research
Verified
Journal Article
Open access
MKMohammad R. Karimijavid
Mohammad R. Karimijavid
APAbdolazim S. Pashaki
Abdolazim S. Pashaki
SBShiva Borzouei
Shiva Borzouei
EKElham Khanlarzadeh
Elham Khanlarzadeh
MGMohammad H. Gholami
Mohammad H. Gholami
SNSafoora Nikzad
Safoora Nikzad
Background: This study aims to evaluate the risk of hypothyroidism (HT) after radiotherapy (RT) of breast and supraclavicular in patients with breast cancer (BC). Materials and Methods: In a historical cohort study, the records of all patients with BC who had been referred to the Mahdieh radiotherapy Center of Hamadan from 2017 to 2019 were reviewed. Demographic characteristics, clinical information, previous and current used treatment methods (surgery, radiotherapy, chemotherapy), number of RT sessions and doses, and HT (TSH >5 mIU/L) were extracted from the patient's documents. Data were analyzed using SPSS software version 16. Results: Out of 304 patients referred to the Center, 266 patients were investigated. The mean TSH was 6.3 ± 7.9 ml/L (1.5 to 65.4). Approximately half of the patients were in Stage 2 of the disease. 37 (16.4%) patients were diagnosed with HT, of which 8.8% were clinical, and 7.5% were subclinical. The mean total dose of HT patients (5621.62 ± 491.67) was significantly higher than other patients (5304.76 ± 937.98). 21 patients (56.8%) in Stage 3 and 4 and 16 (43.2%) patients in Stages 1 and 2 had HT (P = 0.006). Spearman correlation coefficient showed that there was a significant relationship between total dose and TSH hormone (r = 0.624), the number of RT sessions with TSH hormone (r = 0.237), and total dose with T4 hormone (r = -0.232). Conclusion: The findings of this study showed that the risk of HT increases significantly in patients with BC who undergo RT of breast and supraclavicular. Patients with higher stage, more radiation, and more RT sessions are at higher risk of HT.